Association between the angiotensin-converting enzyme (insertion/ deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 1, 2009, Pages 51-58

  Alves Corrěma, Silvana Aparecida ^a   Ribeiro de Noronha, Samuel Marcos ^a   Nogueira de Souza, Naiara Correa ^a   Valleta de Carvalho, Cristina ^a   Massad Costa, Ana Maria ^a   Juvenal Linhares, José ^a   Vieira Gomes, Mariano Tamura ^a   Guerreiro da Silva, Ismael Dale Cotrim ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II type 1 receptor; Angiotensin converting enzyme; Breast cancer; Genotyping; Polymorphisms

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; AGED; ARTICLE; BRAZIL; BREAST CANCER; CANCER GROWTH; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; BRAZIL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PREMENOPAUSE; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 67650508043     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309102317     Document Type: Article

References (38)

1. Sayed-Tabatabaei FA, Oostra BA, Isaacs A., van Duijn CM, Witteman JCM. ACE polymorphisms. Circ Res 2006;98:1123-33.
2. de Gasparo M., Catt KJ, Inagami T., Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-72.
3. Wolf G., Ziyadeh FN, Helmchen U., Zahner G., Schroeder R., Stahl RA ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop. Am J Physiol 1995;268:F940-7.
4. Stoll M., Meffert S., Stroth U., Unger T. Growth or anti-growth: angiotensin and the endothelium. J Hypertens 1995;13:1529-34.
5. Tian Y., Balla T., Baukal AJ, Catt KJ Growth responses to angiotensin II in bovine adrenal glomerulosa cells. Am J Physiol 1995;268:E135-44.
6. Fujita M., Hayashi I., Yamashina S., Itoman M., Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002;294:441-7.
7. Muscella A., Greco S., Elia MG, Storelli C., Marsigliante S. Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol 2002;173:315-23.
8. Nakajima M., Hutchinson HG, Fujinaga M. et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain of function study using in vivo gene transfer. Proc Natl Acad Sci U S A 1995;92:10663-7.
9. De Paepe B., Verstraeten VL, De Potter CR, Vakaet LA, Bullock GR Increased angiotensin II type-2 receptor density in hyperplasia. DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression. Histochem Cell Biol 2002;116:247-54.
10. Inwang ER, Puddefoot JR, Brown CL et al. Angiotensin II type 1 receptor expression in human breast tissues. Br J Cancer 1997;75:1279-83.
11. Marsigliante S., Resta L., Muscella A., Vinson GP, Marzullo A., Storelli C. AT1 angiotensin II receptor subtype in the human laryns and squamous laryngeal carcinoma. Cancer Lett 1996;110 (1-2):19-27.
12. Takeda H., Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 2001;158:1633-7.
13. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol F., Soubrier FJ An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Clin Invest 1990;86:1343-6.
14. Curnow KM, Pascoe L., White PC Genetic analysis of the human type-1 angiotensin II receptor. Mol Endocrinol 1992;6:1113-18.
15. Davies E., Bonnardeaux A., Lathrop GM, Corvol P., Clauser E., Soubrier F. Angiotensin II (type I) receptor locus: CA repeat polymorphism and genetic mapping. Hum Mol Genet 1994;3:83-4.
16. Furuta H., Guo DF, Inagami T. Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem Biophys Res Commun 1992;183:8-13.
17. Bonnardeaux A., Davies E., Jeunemaitre X. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-9.
18. Castellano M., Muiesan ML, Beschi M. et al. Angiotensin II type 1 receptor A/C1166 polymorphism: Relationships with blood pressure and cardiovascular structure. Hypertension 1996;28:1076-80.
19. Amant C., Hamon M., Bauters C. et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997;29:486-90.
20. Talamine R., Franceschi S., Favero A., Negri E., Parazzini F., La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997;75:1699-703.
21. Peeters PH, van Noord PA, Hoes AW, Fracheboud J., Gimbrere CH, Grobbee DE Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens 2000;18:249-54.
22. Mack TM, Henderson BE, Gerkins VR, Arthur M., Baptista J., Pike MC Reserpine and breast cancer in a retirement community. N Engl J Med 1975;292:1366-71.
23. Lever AF, Hole DJ, Gillis CR et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-84.
24. Meier CR, Derby LE, Jick SS, Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med 2000;160:349-53.
25. Koh WP, Yuan JM, Sun CL et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003;63:573-8.
26. Haiman CA, Henderson SO, Bretsky P., Kolonel LN, Henderson BE Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: The multiethnic cohort. Cancer Res 2003;63:6984-7.
27. Freitas-Silva M., Pereira D., Coelho C., Bicho M., Lopes C., Medeiros R. Angiotensin I converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet 2004;155:42-6.
28. Correa SAA, Franca LP, Costa-Neto CM, Oliveira L., Paiva AC, Shimuta SI Relevant role of Leu265 in helix VI of the angiotensin AT1 receptor in agonist binding and activity. Can J Physiol Pharmacol 2002;80:426-30.
29. Correa SAA, Zalcberg H., Han SW et al. Aliphatic amino acids in helix VI of the AT1 receptor play a relevant role in agonist binding and activity. Regul Pept 2002;106:33-8.
30. Correa SAA, Pacheco NAS, Costa-Neto CM et al. New mutants of angiotensin II AT1 receptor expressed in CHO cells caused morphological change and inhibition of cell growth. Regul Pept 2005;131:18-22.
31. Koh WP, Yuan JM, Van Den Berg D., Lee HP, Yu MC Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005;26:459-64.
32. Szombathy T., Jánoskúti L., Szalai C. et al. Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome. Am Heart J 2000;139:101-5.
33. Fukazawa R., Sonobe T., Hamamoto K. et al. Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res 2004;56:597-601.
34. Wang JG, Staessen JA Genetic polymorphisms in the renin-angiotensin system: Relevance for susceptibility to cardiovascular disease. Eur J Pharmacol 2000;410:289-302.
35. Lee EJ Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 1994;37:212-14.
36. Morise T., Takeuchi Y., Takeda R. Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet 1994;343:125.
37. Sanderson JE, Young RP, Yu CM, Chan S., Critchley JA, Woo KS Lack of association between insertion/deletion polymorphism of the angiotensin converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilate cardiomyopathy in the Chinese. Am J Cardiol 1996;77:1008-10. 38. Young RP, Thomas GN, Critchley JA, Tomlinson B., Woo KS, Sanderson JE Interethnic differences in coronary heart disease mortality in 25 populations: Association with the angiotensin-converting enzyme DD genotype frequency. J Cardiovasc 1998;5:303-7.
38. Méthot J., Hamelin BA, Arsenault M., Bogaty P., Plante S., Poirier P. The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women. Menopause 2006;13:959-66.